--- title: Biologics (Other) CDMOs in Asia-Pacific path: /modalities/biologics-other/apac companies_count: 28 --- # Biologics (Other) CDMOs in Asia-Pacific 28 published CDMOs match Biologics (Other) in Asia-Pacific. Locations in this set include United States, China, India, Japan, United Kingdom, and Germany. Capabilities that show up most often in this set: CMC Analytical Development, Process Development, Formulation Development, Quality Control Testing, and Technology Transfer. ## Matching companies - [AGC Biologics](/companies/agcbio) - Global CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities. - [Ajinomoto Bio-Pharma Services](/companies/ajibio-pharma) - Ajinomoto Bio-Pharma Services is a global contract development and manufacturing organization (CDMO) dedicated to improving the health of humankind through adaptive solutions and responsive service. - [Akums Drugs and Pharmaceuticals Ltd.](/companies/akums) - India's largest CDMO with 15+ state-of-the-art facilities and 30% domestic market share, manufacturing 4,100+ formulations across tablets, capsules, injectables, APIs, and specialty dosage forms under WHO-GMP, USFDA, EU-GMP, and TGA compliance. - [Almac Group](/companies/almacgroup) - Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities. - [Altruist Biologics](/companies/altruist-biologics) - Global CDMO offering end-to-end development and GMP manufacturing for monoclonal antibodies, bispecific antibodies, fusion proteins, recombinant proteins, and antibody-drug conjugates, with facilities in Suzhou and Hangzhou featuring up to 20,000-liter bioreactors. - [Aurigene Pharmaceutical Services Limited](/companies/aurigeneservices) - Integrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries. - [Bailun Biotechnology Co., Ltd.](/companies/fermentorchina) - Bailun manufactures GMP-compliant bioreactors and fermentation systems from lab scale (0.5 mL) to 5000 L industrial capacity, with 25+ years of experience serving pharmaceutical, vaccine, and precision fermentation applications across 100+ global projects. - [Biocon](/companies/biocon) - Fully integrated biopharmaceutical company developing affordable biosimilars, generic formulations, and complex APIs for diabetes, cancer, and autoimmune diseases. - [Boston Institute of Biotechnology, LLC](/companies/bostonbib) - Full-service CDMO offering cGMP and non-GMP mammalian, microbial, gene therapy, and cell therapy manufacturing from preclinical to commercial scale, with bioreactor capacity up to 50,000L. - [Catalent](/companies/catalent) - Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply. - [Charles River Laboratories](/companies/criver) - Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years. - [Curia](/companies/curiaglobal) - Global CDMO with 30+ years of experience offering integrated services across small molecule, generic APIs, sterile drug product, and biologics manufacturing, backed by 20+ facilities and 3,000+ professionals across North America, Europe, and India. - [Dr. Reddy's Laboratories](/companies/drreddys) - Integrated global pharmaceutical company manufacturing generics, APIs, biosimilars, and innovative medicines across 66 countries with capabilities in small molecule and biologics development and manufacturing. - [Enzene Biosciences](/companies/enzene) - Global CDMO specializing in cost-effective biologics and biosimilars manufacturing using patented continuous bioprocess technology (EnzeneX®). Offers integrated drug discovery, development, and manufacturing services with facilities in India and expanding presence in the USA and Europe. - [FUJIFILM Biotechnologies](/companies/fujifilm-biotechnologies) - CDMO partner offering end-to-end biologics development and manufacturing from pre-clinical through commercialization, with expertise in cell culture, microbial fermentation, cell and gene therapy, and cGMP manufacturing across US and European facilities. - [Genevoyager (Wuhan) Co., Ltd.](/companies/genevoyager-2) - Leading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023. - [Gland Pharma Limited](/companies/gland-pharma) - Gland Pharma is a vertically integrated CDMO offering sterile injectable manufacturing across vials, lyophilized, prefilled syringes, and ophthalmic formats, with four cGMP-compliant formulation facilities and four API manufacturing units, supported by R&D capabilities in formulation, analytical, and process development. - [Lupin Limited](/companies/lupin) - Global pharmaceutical manufacturer with robust quality systems aligned to US FDA, UK MHRA, and EU GMP standards; operates diversified manufacturing across generics, complex formulations, and specialty segments with advanced automation and digital quality infrastructure. - [Minaris Advanced Therapies](/companies/wuxi-advanced-therapies) - Pure-play cell and gene therapy CDMO with over 25 years of GMP manufacturing, process development, and biosafety testing expertise. Serves advanced therapy innovators globally from early stage through commercialization. - [Pharmaron](/companies/pharmaron) - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.